ArticleWorld journal of surgical oncology2025
E2F7 promotes ESCC progression and cisplatin resistance through transcriptional activation of DVL3 and the Wnt signaling pathway.
Xiaoxu Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.